c-peptide and ciamexon

c-peptide has been researched along with ciamexon* in 1 studies

Other Studies

1 other study(ies) available for c-peptide and ciamexon

Article	Year
Influence of ciamexon on blood glucose and insulin requirement in newly manifested type I diabetics. Results of a pilot study. Arzneimittel-Forschung, 1988, Volume: 38, Issue:8 Treatment with the selectively immunomodulatory drug 1-[2-methoxy-6-methyl-3-pyridinyl)methyl]-2-aziridine-carbonitrile (ciamexon, BM-42332), an aziridine derivative, of newly diagnosed type I diabetic patients is reported. In an open pilot study the treatment of Cx led to the independence of insulin in 33.3% of the treated patients. Topics: Adjuvants, Immunologic; Adolescent; Adult; Antibodies, Viral; Autoantibodies; Aziridines; Azirines; Blood Glucose; C-Peptide; Chemical Phenomena; Chemistry; Diabetes Mellitus, Type 1; Female; Glycated Hemoglobin; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Male	1988

Article

Year

Influence of ciamexon on blood glucose and insulin requirement in newly manifested type I diabetics. Results of a pilot study.

Arzneimittel-Forschung, 1988, Volume: 38, Issue:8

Treatment with the selectively immunomodulatory drug 1-[2-methoxy-6-methyl-3-pyridinyl)methyl]-2-aziridine-carbonitrile (ciamexon, BM-42332), an aziridine derivative, of newly diagnosed type I diabetic patients is reported. In an open pilot study the treatment of Cx led to the independence of insulin in 33.3% of the treated patients.

Topics: Adjuvants, Immunologic; Adolescent; Adult; Antibodies, Viral; Autoantibodies; Aziridines; Azirines; Blood Glucose; C-Peptide; Chemical Phenomena; Chemistry; Diabetes Mellitus, Type 1; Female; Glycated Hemoglobin; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Male

1988